Hepatoblastoma – a rare liver cancer in children

submitted by: mdanderson

Hepatoblastoma is rare, but it’s the most primary liver tumor in children. Right now there are 100 new cases each year in the United States, but that number is gradually increasing. Susan Abraham, M.D., professor in Pathology at MD Anderson Cancer Center, discusses hereditary risks, survival, symptoms, diagnosis and treatment, including liver transplantation for hepatoblastoma patients.

Cancer screening – what you should know

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/cancer-screening-what-you/id43184821... The standard screenings for cancer are for breast, cervical, prostate and colon. For those in a high-risk category, lung, ovarian and liver cancer screenings may be recommended. Therese Bevers, M.D., medical director of Cancer Prevention at MD Anderson Cancer Center, discusses MD Anderson’s cancer screening recommendations and explains the conflicting cancer screening reports.

Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers

submitted by: gastro@scivee

Dr. Heimbach discusses her manuscript "Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers." To view full-text version of this article, go to http://bit.ly/MyJzSD

Proton Therapy Treatment for Liver Cancer

submitted by: mdanderson
Proton therapy has several advantages in treating liver cancer over traditional radiation therapy. Since the proton beam is so exact, larger dosages of radiation can be applied to the affected area, while sparing surrounding healthy tissue. Proton therapy also successfully addresses technical challenges, including liver movement during treatment when the patient breathes. Christopher Crane, M.D., Professor in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer...